Pascal is a seasoned high tech entrepreneur and investor. He sold his first company, 321Auto-Mixad, one of the leading automotive websites in France, to PriceMinister and then studied nanomedicine at Oxford University, with a focus on gene therapy.

​

​

Pascal is graduated from the Ecole Polytechnique and holds an MBA from Columbia University.

​

Thierry is a veteran of the pharmaceutical industry, having successfully brought innovative biologics to clinics and commercial (proteins, cell and gene therapy products). A former head of biopharmaceutics development at SANOFI, he then led the construction and launch of a GMP production plant for CELLECTIS.

​

​

Thierry is graduated from the UTC Compiègne and holds an MSc and a PhD from the Georgia Institute of Technology.